glp-1 receptor agonist creatine interaction Dietary supplement considerations during glucagon-like Peptide-1 treatment: A narrative review Current Insights, Advantages and Challenges
Description
Short-acting GLP-1RAs like exenatide and lixisenatide are associated with transient (112 h) increases, causing a maximum heart rate increase of 810 beats per minute (bpm) 24 h after injection, which returned to baseline after approximately 1012 h, with a mean 24 h heart rate increase of approximately 12 bpm for both GLP-1RAs in healthy adults ( Linnebjerg et al

In healthy human volunteers, intravenous GLP-1 decelerates gastric emptying after the first meal to a greater extent than after a second meal, indicating that GLP-1 inhibition of gastric emptying undergoes rapid desensitization [803]

Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists

Cui Y, Liao M, Xu A, Chen G, Liu J, Yu X, et al

Chris Serres: Exactly

This example demonstrates how acquisition can shortcut capacity growth, but at the cost of a complex transfer and harmonization process
